Two distinct classes of muscarinic action on hippocampal inhibitory synapses:: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling

被引:193
作者
Fukudome, Y
Ohno-Shosaku, T
Matsui, M
Omori, Y
Fukaya, M
Tsubokawa, H
Taketo, MM
Watanabe, M
Manabe, T
Kano, M
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo, Japan
[3] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan
[4] Natl Inst Physiol Sci, Okazaki, Aichi 444, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan
关键词
inhibitory transmission; mouse; rat; synaptic modulation;
D O I
10.1111/j.0953-816X.2004.03384.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The cholinergic system in the CNS plays important roles in higher brain functions, primarily through muscarinic acetylcholine receptors. At cellular levels, muscarinic activation produces various effects including modulation of synaptic transmission. Here we report that muscarinic activation suppresses hippocampal inhibitory transmission through two distinct mechanisms, namely a cannabinoid-dependent and cannabinoid-independent mechanism. We made paired whole-cell recordings from cultured hippocampal neurons of rats and mice, and monitored inhibitory postsynaptic currents (IPSCs). When cannabinoid receptor type 1 (CB1) was blocked, oxotremorine M (oxo-M), a muscarinic agonist, suppressed IPSCs in a subset of neuron pairs. This suppression was associated with an increase in paired-pulse ratio, blocked by the M-2-prefering antagonist gallamine, and was totally absent in neuron pairs from M-2-knockout mice. When CB1 receptors were not blocked, oxo-M suppressed IPSCs in a gallamine-resistant manner in cannabinoid-sensitive pairs. This suppression was associated with an increase in paired-pulse ratio, blocked by the CB1 antagonist AM281, and was completely eliminated in neuron pairs from M-1/M-3-compound-knockout mice. Our immunohistochemical examination showed that M-2 and CB1 receptors were present at inhibitory presynaptic terminals of mostly different origins. These results indicate that two distinct mechanisms mediate the muscarinic suppression. In a subset of synapses, activation of M-2 receptors at presynaptic terminals suppresses GABA release directly. In contrast, in a different subset of synapses, activation of M-1/M-3 receptors causes endocannabinoid production and subsequent suppression of GABA release by activating presynaptic CB1 receptors. Thus, the muscarinic system can influence hippocampal functions by controlling different subsets of inhibitory synapses through the two distinct mechanisms.
引用
收藏
页码:2682 / 2692
页数:11
相关论文
共 51 条
[1]  
ABE T, 1992, J BIOL CHEM, V267, P13361
[2]   SIGNAL TRANSDUCTION AND PHARMACOLOGICAL CHARACTERISTICS OF A METABOTROPIC GLUTAMATE RECEPTOR, MGLUR1, IN TRANSFECTED CHO CELLS [J].
ARAMORI, I ;
NAKANISHI, S .
NEURON, 1992, 8 (04) :757-765
[3]   CHOLINERGIC MODULATION OF SYNAPTIC INHIBITION IN THE GUINEA-PIG HIPPOCAMPUS INVITRO - EXCITATION OF GABAERGIC INTERNEURONS AND INHIBITION OF GABA-RELEASE [J].
BEHRENDS, JC ;
TENBRUGGENCATE, G .
JOURNAL OF NEUROPHYSIOLOGY, 1993, 69 (02) :626-629
[4]   Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors [J].
Bellingham, MC ;
Berger, AJ .
JOURNAL OF NEUROPHYSIOLOGY, 1996, 76 (06) :3758-3770
[5]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[6]  
Caulfield MP, 1998, PHARMACOL REV, V50, P279
[7]  
Chaudhry FA, 1998, J NEUROSCI, V18, P9733
[8]   Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability [J].
Chevaleyre, V ;
Castillo, PE .
NEURON, 2003, 38 (03) :461-472
[9]   Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids [J].
Diana, MA ;
Levenes, C ;
Mackie, K ;
Marty, A .
JOURNAL OF NEUROSCIENCE, 2002, 22 (01) :200-208
[10]   Therapeutic opportunities for muscarinic receptors in the central nervous system [J].
Felder, CC ;
Bymaster, FP ;
Ward, J ;
DeLapp, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (23) :4333-4353